ConductScience.org, home

Gene · 2395

NIH grants1,467

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleFXN papersNewest fiscal year
P30ES013508Center of Excellence in Environmental Toxicology192025
ZIAHD008814Mammalian iron-sulfur cluster biogenesis182025
ZIAHD001602Regulation Of Intracellular Iron Metabolism112025
ZIADK057602The consequences of the unusual mutation responsible for the Repeat Expansion Diseases92025
R35GM118103Recognition of Cellular Targets by single and double-stranded nucleic acids82025
R01NS072248Genome Studies in Hereditary Spastic Paraplegia- Beyond the Exome72025
R01NS121038Defining the impact of Frataxin point mutations on Friedreich's ataxia pathogenesis62025
R35GM130322Mechanisms of Genome Instability Mediated by Simple DNA Repeats62025
T32ES019851Translational Research Training Program in Environmental Health Sciences62025
P01CA092584Structural Cell Biology of DNA Repair Machines52025
UL1TR001878Institutional Clinical and Translational Science Award52025
ZIADK057808Understanding the mutational mechanism responsible for the Repeat Expansion Diseases52025
R01CA093729Repair of Genome Destabilizing DNA Structures42025
U42OD011158Research Resource for Human Organs and Tissues42025
P30CA016672Cancer Center Support Grant32025
P40OD018537Bloomington Drosophila Stock Center at Indiana University32025
P51OD011107California National Primate Research Center32025
R01HL113006Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling32025
R01HL124021An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH32025
U01HG011755Broad Institute Mendelian Genomic Research Center32025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2395/grants